Ignite Creation Date:
2025-12-25 @ 4:14 AM
Ignite Modification Date:
2026-05-27 @ 8:55 AM
Study NCT ID:
NCT01117220
Status:
WITHDRAWN
Last Update Posted:
2021-02-21
First Post:
2010-05-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety And Efficacy Of Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed) (Protocol A1281196)
Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
A1281196
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None